<p>Six series of ether (<b>14a</b>–<b>i</b> and <b>15a</b>–<b>i</b>), ester (<b>17a</b>–<b>f</b> and <b>18a</b>–<b>f</b>) and amine derivatives (<b>21a</b> and <b>22a</b>–<b>g</b>) containing quinoxalinyl and quinolinyl moieties were synthesized and evaluated for their inhibitory activities against activin receptor-like kinase 5 (ALK5). Among all the compounds, compound <b>22f</b> (IC<sub>50</sub> = 0.267&#xa0;μM) exhibited the highest ALK5 inhibitory activity, comparable to that of the positive control <b>LY-2157299</b>. This study revealed that introducing amino groups into the side chains of quinoxalinyl and quinolinyl derivatives is more effective in enhancing ALK5 inhibition than ether or ester groups. These findings provide new insights and a theoretical foundation for the development of pyrazole-based ALK5 inhibitors.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Design, synthesis, and biological evaluation of quinoxalinyl and quinolinyl derivatives as ALK5 inhibitors

  • Chuang Liu,
  • Jun Li,
  • Yu-Qi Lu,
  • Yu-Xin Jiang,
  • Cheng-Hua Jin

摘要

Six series of ether (14ai and 15ai), ester (17af and 18af) and amine derivatives (21a and 22ag) containing quinoxalinyl and quinolinyl moieties were synthesized and evaluated for their inhibitory activities against activin receptor-like kinase 5 (ALK5). Among all the compounds, compound 22f (IC50 = 0.267 μM) exhibited the highest ALK5 inhibitory activity, comparable to that of the positive control LY-2157299. This study revealed that introducing amino groups into the side chains of quinoxalinyl and quinolinyl derivatives is more effective in enhancing ALK5 inhibition than ether or ester groups. These findings provide new insights and a theoretical foundation for the development of pyrazole-based ALK5 inhibitors.